Suppr超能文献

钙通道拮抗剂对原发性高血压患者左心室肥厚及舒张功能的影响。

Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.

作者信息

Takami Takeshi, Shigematsu Minori

机构信息

Clinic Jingumae, Kashihara, Nara, Japan.

出版信息

Clin Exp Hypertens. 2003 Nov;25(8):525-35. doi: 10.1081/ceh-120025336.

Abstract

Hypertensive patients characteristically exhibit left ventricular (LV) hypertrophy and diastolic dysfunction. The effects of antihypertensive agents on LV hypertrophy and diastolic dysfunction do not always correlate with the degree of blood pressure reduction, but their effects on the sympathetic nervous system and renin-angiotensin system (RA system) are thought to be important. We investigated the effects of amlodipine and cilnidipine, N- and L-type calcium channel antagonists that suppress both blood pressure elevation and sympathetic activities, on LV hypertrophy and diastolic function. Patients with essential hypertension were randomly assigned to receive either amlodipine, cilnidipine or nifedipine CR (which does not block N-type calcium channels) for 6 months. The LV mass index was determined using M-mode echocardiography. The E/A ratio, i.e., the ratio of maximum amplitude between the early diastolic wave (E wave) and the atrial systolic wave (A wave) in the LV inflow pattern, and the deceleration time for the E wave were determined using pulse Doppler echocardiography. Systolic and diastolic blood pressures significantly decreased from the baseline values in all three groups, with no significant differences among the groups. The LV mass index had significantly decreased when it was evaluated 3 months after the initiation of treatment in the cilnidipine group and when it was evaluated 6 months after the initiation of treatment in the amlodipine group; only a slight decrease was observed in the nifedipine CR group. A significant decrease in the deceleration time and a significant increase in the E/A ratio were observed after 3 months of treatment in the cilnidipine and amlodipine groups but not in the nifedipine CR group. Thus, the effects of long-acting calcium channel antagonists on hypertensive LV hypertrophy and LV diastolic function varied from one antagonist to the other. Left ventricular hypertrophy and diastolic function improved in the cilnidipine and amlodipine groups, but not in the nifedipine CR group. These results indicate that the suppression of sympathetic nerve activity by the blockade of N-type calcium channels contributes to the improvement of LV hypertrophy and diastolic function.

摘要

高血压患者通常表现为左心室(LV)肥厚和舒张功能障碍。抗高血压药物对LV肥厚和舒张功能障碍的影响并不总是与血压降低程度相关,但它们对交感神经系统和肾素 - 血管紧张素系统(RA系统)的作用被认为是重要的。我们研究了氨氯地平和西尼地平(N型和L型钙通道拮抗剂,可抑制血压升高和交感神经活动)对LV肥厚和舒张功能的影响。原发性高血压患者被随机分配接受氨氯地平、西尼地平或硝苯地平控释片(不阻断N型钙通道)治疗6个月。使用M型超声心动图测定LV质量指数。使用脉冲多普勒超声心动图测定E/A比值,即LV流入模式中舒张早期波(E波)与心房收缩波(A波)之间的最大振幅比值,以及E波的减速时间。三组患者的收缩压和舒张压均较基线值显著降低,组间无显著差异。在西尼地平组治疗开始3个月后评估时,LV质量指数显著降低;在氨氯地平组治疗开始6个月后评估时,LV质量指数也显著降低;硝苯地平控释片组仅观察到轻微降低。在西尼地平和氨氯地平组治疗3个月后,观察到减速时间显著缩短,E/A比值显著升高,而硝苯地平控释片组未观察到。因此,长效钙通道拮抗剂对高血压LV肥厚和LV舒张功能的影响因拮抗剂不同而有所差异。西尼地平和氨氯地平组的左心室肥厚和舒张功能得到改善,而硝苯地平控释片组未改善。这些结果表明,通过阻断N型钙通道抑制交感神经活动有助于改善LV肥厚和舒张功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验